As interest in taking glucagon-like peptide-1 receptor agonist (GLP-1 agonist) medications, such as Zepbound and Wegovy, for weight loss, research continues to examine potential new side effects of these types of drugs
Once-weekly subcutaneous injection Compounded by state-licensed pharmacies Up to ~21% body weight reduction at 72 weeks (SURMOUNT-1) No insurance required shipping doctors doctor 24/7 Same price at every dose
Who will be overseeing my care at Zealthy
The FDA does not review compounded versions for safety, effectiveness, or quality before dispensing
58 GLP-1RAs potentially may reduce the risk of AF onset and progression through direct and indirect effects on atrial remodelling, including a reduction in systemic inflammation, improvement of cardiomyocyte metabolism, autonomic nervous system modulation, regulation of intracellular Ca 2+ levels and prevention and possibly reversion of atrial fibrosis
Do not use if the reconstituted solution is cloudy or contains visible particles